about
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a ...
Read More
4.21
-0.12
(-2.77%)
2.6M
XNAS Volume
High vol.+loss this week
XNAS 24 Sep, 2025 12:18 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Replimune Group Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..